Singapore markets close in 3 hours 2 minutes

NeuBase Therapeutics Inc (O7P.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.35100.0000 (0.00%)
At close: 08:27AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2022
30/09/2021
30/09/2020
30/09/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
18,431
21,449
14,363
6,946
16,415
Selling general and administrative
11,530
11,870
12,202
10,123
9,096
Total operating expenses
29,961
33,318
26,565
17,069
25,510
Operating income or loss
-29,961
-33,318
-26,565
-17,069
-25,510
Interest expense
10.696
24.047
32.33
7.686
128.951
Total other income/expenses net
-739.692
-582.62
1,176
-307.528
-492.889
Income before tax
-30,417
-33,776
-25,409
-17,385
-26,132
Income from continuing operations
-30,417
-33,776
-25,409
-17,385
-26,132
Net income
-30,417
-33,776
-25,409
-17,385
-26,132
Net income available to common shareholders
-30,417
-33,776
-25,409
-17,385
-26,132
Basic EPS
-3.44
-20.80
-18.60
-17.80
-65.20
Diluted EPS
-3.44
-20.80
-18.60
-17.80
-65.20
Basic average shares
2,825
1,624
1,365
981.014
413.585
Diluted average shares
2,825
1,624
1,365
981.014
413.585